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ABSTRACT 
Purpose: A number of studies have demonstrated the importance of using surgical clips to define the tumour bed in 
breast boost radiotherapy. In the absence of such clips, other techniques suggested to improve boost location have 
included CT and ultrasound (US). Determination of the depth of the tumour bed is important in the selection of electron 
energy. This study was conducted to prospectively compare the depth of the lumpectomy cavity as defined by ultrasound 
to radiographic plain film evaluation of the anterior border of the pectoralis muscle. 
Materials and Methods: Forty-one breast-cancer patients treated at the Division of Therapeutic Radiology and 
Oncology,
  Department of Radiology, Faculty of Medicine, Chiang Mai University between December 2004 and 
December 2006 were prospectively identified as having no surgical clips within the lumpectomy cavity. All patients 
underwent both US evaluation of the depth of tumour bed (D1) and radiographic evaluation of the depth of the anterior 
border of the pectoralis muscle (D2). These depth dimensions (D1 and D2) were compared using a paired t-test. The 
correlation of both methods was analyzed by Pearson correlation test. 
Results: Depth dimensions by US were shorter than the radiographic film method in 85% of patients. The absolute 
mean difference of the depth (radiographic films minus US) was 0.129 cm. A paired t-test demonstrated that the 
difference between these two methods to be not statistically significant (p= 0.27). The absolute difference of depth 
between the two methods ranged from 0 to 0.5 cm. A significant correlation was found between US and radiographic 
film measurements (p<0.01).  
Conclusion: Plane radiographic film evaluation of the anterior border of the pectoralis muscle can be used to define 
the depth of the tumour bed in patients who have no surgical clips. However, the plane radiographic film method 
determines only the depth, not the transverse and longitudinal dimensions of the tumour bed. Additional information 
from US is needed to delineate the target volume for the 
tumour bed boost. In the absence of surgical clips, the 
authors recommend integration of both methods in breast 
boost planning process. © 2009 Biomedical Imaging and 
Intervention Journal. All rights reserved. 
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Breast conserving surgery followed by external 
beam radiotherapy is one standard treatment of early 
breast cancer. An additional radiation boost dose to the 
tumour bed or lumpectomy cavity is required after breast 
conserving surgery to reduce the risk of local recurrence. 
There are many ways to design the boost fields but no 
standard technique has been established. In a recent 
Patterns of Care Study on early stage breast cancer, the 
breast volume was determined by CT in 11.7%, a clinical 
fluoroscopic simulator in 43.9%, and clinically alone in 
37.2% [1].  
One of the most common planning employs clinical 
information and surgical scars. However, many reports 
have demonstrated the unreliability of this boost 
technique with geographic miss rate ranging from 
43-68% [2-4]. The gold standard tool to guide the design 
of boost field is radiographic evaluation of intra-
operatively placed surgical clips. However, placement of 
surgical clips is not routinely performed by all surgeons. 
In the absence of surgical clips, other techniques 
suggested to improve boost location include computed 
tomography (CT) planning and ultrasound (US) [5-7]. 
Several studies of boost fields using US to identify the 
location and dimensions of the lumpectomy cavity found 
the fields were acceptable in size and that accuracy 
compared favourably to other techniques for boost 
planning [3-10]. However, Rabinovitch et al. 
recommended against using US for breast boost planning 
as it could result in inappropriate selection of low 
electron energies and small field sizes compared to the 
radiographic evaluation of surgical clips [11]. Similarly, 
CT can be used to target the tumour bed with cavity 
visualization similar to US [12], but CT is not available 
in all radiation centres.  
The authors are seeking ways to shorten the process 
of defining the radiation boost plan in order to improve 
working practice at the Division of Therapeutic 
Radiology and Oncology where 200 patients were treated 
daily. Focusing on patients who had no clip placement, 
the authors conducted this study to compare the depth of 
the lumpectomy cavity as defined by ultrasound 
technique to radiographic plain film evaluation of the 
anterior border of the pectoralis muscle. The authors 
wished also to explore these relatively easy techniques of 
delineating the surgical bed for the benefit of institutions 
where other advanced techniques are not feasible. This 
study was approved by the Institutional Review Board of 
the Faculty of Medicine, Chiang Mai University.  
MATERIALS AND METHODS 
Between December 2004 and December 2006, 
54  patients underwent excisional biopsy and axillary 
lymph node dissection followed by irradiation at the 
Division of Therapeutic Radiology and Oncology,
 
Department of Radiology, Faculty of Medicine, Chiang 
Mai University. The major inclusion criteria were 
1)  stage I and II breast cancer, 2) negative resection 
margins and 3) no surgical clip placement in the tumour 
bed. Nine patients with surgical clips and four patients 
with positive surgical margins were excluded. Thus, 
41 patients were included in this study.  
Before the day of initial simulation, all patients 
underwent US evaluation of the lumpectomy cavity to 
define all dimensions of the cavity. Dimensions of the 
cavity included transverse measurement (T) (medial to 
lateral), longitudinal measurement (L) (superior to 
inferior) and depth (D1) (skin to the posterior portion of 
the cavity). The extent of the lumpectomy cavity was 
marked on the patient’s skin at the time of US to 
determine the field borders. US was performed using a 
12-5 MHz linear-array transducer (HDI 5000, Advanced 
Technology Laboratories, Bothell, WA, USA) by a 
radiologist. Radiotherapy consisted of treatment to the 
entire breast with medial and lateral tangential fields to a 
total dose of 50 Gy in 2  Gy per fraction with a 6MV 
linear accelerator. The boost field was irradiated by 
electrons between 10 and 16 Gy.  
At the time of initial radiation therapy simulation of 
tangential fields, a lead wire was placed over the 
lumpectomy scar and further films were undertaken for 
boost planning. The techniques used were as described 
by Rabinovitch et al. [11]. Orthogonal films were taken 
with the isocentre at the middle of the scar. The first film 
was taken with the beam perpendicular to the skin 
surface at the surgical scar (treatment direction) 
(Figure  1A, 2A). By using SSD (source-skin distance) 
technique, the second film was taken 90 degrees from the 
first, with the beam tangential to the skin surface 
(Figure  1B, 2B). These films required a couch, gantry 
and collimator rotation to achieve the desired beam 
angles. The depth (D2) from the skin to the anterior 
border of the chest wall muscle was measured from the 
second film. In the absence of clip placement, we could 
not measure the transverse and longitudinal distances 
using the radiographic film. Electron energy was chosen 
by defining “treated depth” (TD) as the higher value 
between the depth to pectoralis muscle from radiographic 
film (D2), and ultrasound cavity depth (D1).  
The depth measurements from US and radiographic 
film were compared using paired t-test. Correlation with 
the depth measurements from US and radiographic film 
were determined by the Pearson’s test. 
RESULTS 
Forty-one patients were treated in this study. 
Patients and tumour characteristics are listed in Table 1. 
The median age was 45 years (range: 27-58). The 
majority of tumours were between 2.1 and 3.0 cm in 
diameter. Most patients (87.8%) received chemotherapy 
before RT. The median interval between surgery and US 
was 24 weeks (range: 1 - 48). Table 2 gives the mean of 
the measured depth results for D1 and D2 and the mean of 
the absolute difference in depths (i.e. absolute mean of 
D2  – D1). The absolute mean difference of the depth 
(radiographic films minus US) was 0.129 cm. The 
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Figure 1  Diagram of electron beam direction (A) Treated direction, (B) 90 degree from treated direction. 
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Figure 2  Orthogonal radiographic film of (A) Treated direction, (B) 90 degree from treated direction. 
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Figure 3  Correlation coefficients between the two measurement methods. 
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absolute depth discrepancy between the two methods 
ranged from 0 to 0.5 cm. A paired t-test demonstrated no 
statistically significant difference between US and plain 
film measurements (p=0.27). The Pearson’s correlation 
coefficients between depth dimensions estimated by US 
and by radiographic film was 0.98 (n = 41). (repeated) 
For this study, the chosen electron energy was based 
on the deepest extent (regardless of method of 
measurement: US or orthogonal film) and the field 
borders were defined by marking the extent of the 
lumpectomy cavity on the patient’s skin at the time of 
US: i.e. information from both the plane radiographic 
film and US was used in the planning of the radiation 
boost treatment. In two patients whose intervals from 
surgery to US were more than 40 weeks, US evaluation 
was of no value due to lack of identifiable cavity. 
Median follow-up time was 47 months (range: 30- 52). 
Two of the 41 patients (4.9%) developed a local 
recurrence of the breast cancer outside the boost area at 
25 months and 27 months, respectively, after completion 
of radiotherapy. One of them also developed lung 
metastases and eventually died. At the time of analysis, 
40 patients were still alive with no evidence of disease.  
DISCUSSION 
Although CT-based planning with surgical clips 
remains the most accurate method to delineate the 
tumour bed, this is not possible with all patients: some do 
not have surgical clips placed, and some radiation 
facilities do not have access to CT for this planning. In 
the absence of surgical clips, Rabinovitch et al. [11] 
recommended using CT-guided treatment planning. 
Smitt et al. [5] published information on the use of CT in 
the absence of surgical clips to visualize the lumpectomy 
cavity and found results similar to those obtained with 
US. Conversely where equipment is limited, several 
studies have found that fluoroscopy of surgical clips is a 
fairly precise method of delineating the surgical cavity [2, 
4, 8, 11, 13].  
This study considered the options for patients 
without surgical clips and where CT is not available. 
Previous studies [13, 14] have demonstrated successful 
results of using US to localize the lumpectomy cavity 
and facilitate boost field placement in patients treated 
with lumpectomy and radiation therapy but issues can 
arise with US planning alone. The optimal time to 
Table 1  Patients and tumor characteristics. 
  No. of patients  % 
Number of patients                         41  
Median age                         45 (27 - 58)   
Pathological tumor size (cm)      
≤ 1.0     5  12.2 
1.1 - 2.0   14  34.1 
2.1 - 3.0   15  36.7 
3.1 - 4.0     4    9.7 
> 4.0 - 5.0    3    7.3 
Chemotherapy regimen      
CMF × 6   12  29.3 
AC/ EC × 4     4    9.7 
FAC/ FEC × 6   20  48.8 
No  chemotherapy     5  12.2 
Interval from surgery to performing US (weeks)     
≤ 12   11  26.3 
13 - 24   10  23.8 
25 - 36    16  38 
37 - 48     4    9.5 
 
 
Table 2  Comparison of the depth by two methods. 
Mean depth by US (cm)  2.33 
Mean depth by radiographic films (cm)  2.37 
p-value 
(95% CI of the difference) 
0.27 
(-0.103 - 0.03) 
Discrepancy range for depth  between two methods (cm)  0 - 0.5 
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perform US is not known. It should not be performed too 
early following lumpectomy because significant seroma 
fluid or haematoma may exist within the cavity, 
distorting the volume. And it should not be performed 
too late, such as after the end of chemotherapy cycles, 
because a long gap post operatively can cause near 
complete absorption of seroma and lumpectomy cavity 
and US may not be able to estimate the dimensions of the 
surgical bed or even discern any cavity. Almost all the 
patients received chemotherapy before RT except for 
5  patients with tumours of ≤ 1 cm. The common 
chemotherapy regimens were FAC or FEC and half of 
the patients had cycles delayed due to grade 3 or 4 
neutropenia, accounting for the long median time 
between surgery and RT. Two patients (4.8%) had no 
identifiable cavity and both of them had a long interval 
from surgery to US procedure (40 and 48 weeks, 
respectively). Because of this obscuration of the 
lumpectomy cavity with time, an increasing gap between 
surgery and radiotherapy simulation can lead to 
underestimation of the tumour bed and margins by US 
[6,11]. 
In this study, no patients had surgical clips, so 
radiography could only be used to estimate the depth of 
the surgical tumour bed (by measuring the depth from 
the surface to the anterior border of the chest wall) and 
not the transverse and longitudinal dimensions of the 
tumour bed. Radiography alone is therefore inadequate 
for patients without surgical clips. However, as discussed 
above, it is not clear that the cavity identified by US will 
still be accurate, or even visualisable, if several months 
pass before radiation therapy is commenced.  
In this study, depth measurements were obtained 
both from the plane radiograph and from the US. A 
paired t-test demonstrated no statistically significant 
difference between the two methods. Neither was 
consistently deeper than the other. In figure 3, the 
correlation between both measurements was shown that 
there are correlation coefficients between them. To avoid 
geographical miss, the safest approach is therefore to 
integrate both methods and use the deepest of the two 
depth measurements to define the electron energy and 
the US to delineate the radiation field margins. 
Although CT-based planning with surgical clips 
remains the most accurate method to delineate tumour 
bed, fluoroscopy in combination with US is also a fairly 
acceptable technique for boost field delineation. The 
authors would encourage breast surgeons to place 
surgical clips in the walls of the lumpectomy cavity, so 
that further studies can be undertaken to compare the 
transverse and longitudinal dimensions as determined by 
fluoroscopy and US, and to confirm the effectiveness of 
this integrated technique. 
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